Evidence map›Paper›PMID 41837744›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid-T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer.

Athena E Golfinos-Owens, Taja Lozar, Parth Khatri, Evan D Johns, Rong Hu, Paul M Harari, Paul F Lambert, Megan B Fitzpatrick, Huy Q Dinh

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Athena E Golfinos-OwensMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0002-8365-1743
Taja LozarMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0003-2893-5580
Parth KhatriMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0003-1998-5324
Evan D JohnsMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0009-0003-3289-0319
Rong HuDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0002-1502-9848
Paul M HarariDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0002-6207-5505
Paul F LambertMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0001-7983-2755
Megan B FitzpatrickDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0001-7040-8018
Huy Q DinhMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0002-3307-1126

Funding

Visualizing EBV and HCMV DNA Dynamics During InfectionP01CA022443 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WILLIAM M. SUGDEN · 1985 to 2026
$53.1M
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptorsP50CA278595 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Zachary Scott Morris · 2022 to 2026
$12.5M
Defining Drivers of HPV-associated CarcinogenesisR35CA210807 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Paul F. Lambert · 2017 to 2026
$9.2M
National Institutes of Health (NIH) P01CA022443National Institutes of Health (NIH) P50CA278595NCI NIH HHS P01 CA022443NCI NIH HHS P50 CA278595NCI NIH HHS R35 CA210807
6 · The paper itself

Abstract

purposeWe conduct a systematic evaluation of cell-cell interactions between tumor-infiltrating immune cells in patients with head and neck squamous cell carcinoma (HNSCC) who have been treated with immune checkpoint blockade (ICB) using spatial and single-cell omics data. EXPERIMENTAL

designWe employed complementary techniques from both Visium spot-based spatial transcriptomics and CosMx Spatial Molecular Imager single-cell spatial omics, utilizing a 64-plex protein panel and a 1,000-gene RNA panel, which includes 435 ligands and receptors. We conducted integrated bioinformatics analyses to identify cellular neighborhoods of colocalizing cell types and ligand-receptor interactions across different single-cell and spatial data modalities.

resultsWith 522,399 single cells profiled for both RNA and protein from 23 patients, along with spot-resolved spatial RNA sequencing (RNA-seq) data from eight patients treated with ICB, and through bioinformatics analysis of publicly available single-cell and bulk RNA-seq, we identified a spatial and cell type-specific context dependency in the differences in myeloid and T-cell interactions between responder and nonresponder samples. We further defined the cellular neighborhood and sources of chemokine CXCL9/10-CXCR3 interactions, emphasizing the specificity of this marker in responder samples, an emerging target in ICB, as well as other underappreciated markers and targets for ICB response in HNSCC, such as CXCL16-CXCR6 and CCL4/5-CCR5.

conclusionsWe have provided a valuable resource for analyzing spatial and cell-cell ligand-receptor interactions, including the cellular and spatial contexts of ICB response markers. Our data suggest that future mechanistic studies should consider this context specificity when evaluating ICB response biomarkers and targets.

Indexed as

Cell CommunicationHead and Neck NeoplasmsImmune Checkpoint InhibitorsMyeloid CellsSquamous Cell Carcinoma of Head and NeckT-LymphocytesBiomarkers, TumorComputational BiologyHumansLymphocytes, Tumor-InfiltratingSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisSpatial AnalysisSpatial TranscriptomicsTumor MicroenvironmentBiomarkers, TumorImmune Checkpoint Inhibitors

Identifiers

PMID41837744
PMCPMC13093465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.